GlassScriptPhysician profile
Letantia B Bussell
NPI 1437183068
$739.43
in general payments reported to CMS, 2019-2025
14 companies · $67.35 in 2025
The $67.35 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $73.55 · 2021: $46.90 · 2022: $45.14 · 2023: $196 · 2024: $173 · 2025: $67.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $436.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $222.80 | 2020-2024 | Otezla |
| Incyte Corporation | $121.04 | 2024 | Opzelura |
| Allergan, INC. | $97.02 | 2019-2022 | |
| Vyne Pharmaceuticals INC. | $46.90 | 2021 | |
| Abbvie INC. | $45.51 | 2023 | Botox |
| Leo Pharma INC. | $43.84 | 2025 | Anzupgo |
| Dermira, INC. | $31.39 | 2019 | |
| Organogenesis INC. | $28.24 | 2023 | Puraply |
| Surgenex LLC | $23.51 | 2025 | Renograft, Ardeograft, Surmatrix |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $23.13 | 2020 | |
| Phadia US INC. | $17.66 | 2019 | |
| Galderma Laboratories, L.P. | $13.14 | 2020 | |
| Epi Health, LLC | $12.65 | 2019 | |
| Celgene Corporation | $12.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Letantia Bussell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.